As of 2025-09-15, the Relative Valuation of Aptose Biosciences Inc (APS.TO) is - CAD. This relative valuation is based on P/E multiples. With the latest stock price at 1.61 CAD, the upside of Aptose Biosciences Inc based on Relative Valuation is -.
The range of the Relative Valuation is - CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | P/E |
| 2025-09-09 | -0.04 |
| 2025-09-08 | -0.04 |
| 2025-09-05 | -0.04 |
| 2025-09-04 | -0.04 |
| 2025-09-03 | -0.04 |
| 2025-09-02 | -0.04 |
| 2025-08-29 | -0.04 |
| 2025-08-28 | -0.04 |
| 2025-08-27 | -0.04 |
| 2025-08-26 | -0.04 |
| 2025-08-25 | -0.05 |
| 2025-08-22 | -0.04 |
| 2025-08-21 | -0.04 |
| 2025-08-20 | -0.04 |
| 2025-08-19 | -0.05 |
| 2025-08-18 | -0.05 |
| 2025-08-15 | -0.05 |
| 2025-08-13 | -0.05 |
| 2025-08-12 | -0.05 |
| 2025-08-11 | -0.05 |
| 2025-08-08 | -0.05 |
| 2025-08-07 | -0.04 |
| 2025-08-06 | -0.05 |
| 2025-08-05 | -0.05 |
| 2025-08-01 | -0.04 |
| 2025-07-31 | -0.04 |
| 2025-07-30 | -0.05 |
| 2025-07-29 | -0.05 |
| 2025-07-28 | -0.06 |
| 2025-07-25 | -0.06 |
| 2025-07-24 | -0.06 |
| 2025-07-23 | -0.06 |
| 2025-07-22 | -0.06 |
| 2025-07-21 | -0.06 |
| 2025-07-18 | -0.06 |
| 2025-07-17 | -0.06 |
| 2025-07-16 | -0.06 |
| 2025-07-15 | -0.06 |
| 2025-07-14 | -0.06 |
| 2025-07-11 | -0.07 |
| 2025-07-10 | -0.06 |
| 2025-07-09 | -0.05 |
| 2025-07-08 | -0.06 |
| 2025-07-07 | -0.05 |
| 2025-07-04 | -0.03 |
| 2025-07-03 | -0.03 |
| 2025-07-02 | -0.03 |
| 2025-06-30 | -0.03 |
| 2025-06-27 | -0.03 |
| 2025-06-26 | -0.03 |